Nanotechnology-Based Detection of Mycoplasma pneumoniae

基于纳米技术的肺炎支原体检测

基本信息

  • 批准号:
    8522149
  • 负责人:
  • 金额:
    $ 19.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-15 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Mycoplasma pneumoniae is a significant human respiratory tract pathogen, causing bronchitis and atypical or "walking" pneumonia. M. pneumoniae accounts for 20% of all community-acquired pneumonia and is the leading cause of pneumonia in older children and young adults. Serologic testing is the primary method for diagnosis due to the significant challenges posed by direct culture but suffers from severe limitations, including the need for paired sera obtained at separate physician visits, and is thus impractical for rapid diagnosis. PCR can exhibit high sensitivity and yield positive detection sooner but is prone to false-negatives from reaction inhibitors. The inability to provide rapid and definitive diagnosis delays initiation of appropriate treatment, prolongs morbidity, and increases the likelihood of continued transmission, secondary infections, and long-term sequelae, including chronic lung disease associated with COPD and asthma. Lack of a simple, reliable, rapid diagnostic test is thus a critical barrier to improved control of M. pneumoniae disease. Application of nanotechnology to biosensor development is yielding direct, rapid, and sensitive pattern-recognition approaches for detection of infectious agents. We have shown that nanofabrication by glancing angle vapor deposition produces Ag nanorod arrays (NA) exhibiting extremely high electromagnetic field enhancements for surface-enhanced Raman spectroscopy (SERS). Paired with chemometric analysis this platform can rapidly detect and distinguish with outstanding sensitivity and specificity the Raman spectra of viruses and mycoplasmas, and shows great promise in its potential to improve diagnosis of M. pneumoniae infections. Our overall goal is to advance the application of NA-SERS to rapid and sensitive mycoplasma detection in clinical specimens, building upon critical published data that demonstrate its capacity to detect M. pneumoniae at clinically relevant sensitivity in simulated and true clinical throat swab samples. Our application has two specific aims, shifting the project from proof-of-concept toward clinical application: (1) expand analysis of spiked and control samples using throat swabs from a broader cohort, including direct comparison to qPCR; analyze spectral signatures of commensal mycoplasmas and assess their impact on M. pneumoniae detection; and assess NA- SERS discriminatory ability in mixed infections with other bacterial pathogens including Chlamydophila pneumoniae; and (2) test by NA-SERS, true clinical throat swab samples previously established as positive or negative for M. pneumoniae by PCR and culture, in unblinded and blinded analyses; and characterize M. pneumoniae isolates obtained globally to determine whether strain diversity impacts detection by NA-SERS in spiked throat swab samples.
描述(由申请人提供):肺炎支原体是一种重要的人类呼吸道病原体,可引起支气管炎和非典型或“行走”肺炎。肺炎支原体占所有社区获得性肺炎的20%,是大龄儿童和年轻人肺炎的主要原因。由于直接培养带来的重大挑战,血清学检测是诊断的主要方法,但存在严重的局限性,包括需要在单独的医生就诊时获得成对的血清,因此对于快速诊断是不切实际的。PCR可以表现出高灵敏度和产生阳性检测更快,但容易假阴性的反应抑制剂。无法提供快速和有效的服务

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Highly Sensitive Detection and Differentiation of Endotoxins Derived from Bacterial Pathogens by Surface-Enhanced Raman Scattering.
  • DOI:
    10.3390/bios11070234
  • 发表时间:
    2021-07-11
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wu X;Zhao Y;Zughaier SM
  • 通讯作者:
    Zughaier SM
Layer-by-layer polyelectrolyte encapsulation of Mycoplasma pneumoniae for enhanced Raman detection.
肺炎支原体的层层聚电解质封装用于增强拉曼检测。
  • DOI:
    10.1039/c4an00596a
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Rivera-Betancourt,OmarE;Sheppard,EdwardS;Krause,DuncanC;Dluhy,RichardA
  • 通讯作者:
    Dluhy,RichardA
Specificity and Strain-Typing Capabilities of Nanorod Array-Surface Enhanced Raman Spectroscopy for Mycoplasma pneumoniae Detection.
纳米棒阵列表面增强拉曼光谱检测肺炎支原体的特异性和菌株分型能力。
  • DOI:
    10.1371/journal.pone.0131831
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Henderson,KelleyC;Benitez,AlvaroJ;Ratliff,AmyE;Crabb,DonnaM;Sheppard,EdwardS;Winchell,JonasM;Dluhy,RichardA;Waites,KenB;Atkinson,TPrescott;Krause,DuncanC
  • 通讯作者:
    Krause,DuncanC
Culture-free diagnostics of Pseudomonas aeruginosa infection by silver nanorod array based SERS from clinical sputum samples.
The multivariate detection limit for Mycoplasma pneumoniae as determined by nanorod array-surface enhanced Raman spectroscopy and comparison with limit of detection by qPCR.
  • DOI:
    10.1039/c4an01141d
  • 发表时间:
    2014-12-21
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Henderson KC;Sheppard ES;Rivera-Betancourt OE;Choi JY;Dluhy RA;Thurman KA;Winchell JM;Krause DC
  • 通讯作者:
    Krause DC
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DUNCAN C KRAUSE其他文献

DUNCAN C KRAUSE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DUNCAN C KRAUSE', 18)}}的其他基金

Human Airway Colonization by Mycoplasma pneumoniae
肺炎支原体在人呼吸道定植
  • 批准号:
    9058484
  • 财政年份:
    2014
  • 资助金额:
    $ 19.07万
  • 项目类别:
Human Airway Colonization by Mycoplasma pneumoniae
肺炎支原体在人呼吸道定植
  • 批准号:
    8849366
  • 财政年份:
    2014
  • 资助金额:
    $ 19.07万
  • 项目类别:
Human Airway Colonization by Mycoplasma pneumoniae
肺炎支原体在人呼吸道定植
  • 批准号:
    8786665
  • 财政年份:
    2014
  • 资助金额:
    $ 19.07万
  • 项目类别:
Nanotechnology-Based Detection of Mycoplasma pneumoniae
基于纳米技术的肺炎支原体检测
  • 批准号:
    8369123
  • 财政年份:
    2012
  • 资助金额:
    $ 19.07万
  • 项目类别:
18th Congress of the International Organization for Mycoplasmology
国际支原体学组织第十八届大会
  • 批准号:
    7904700
  • 财政年份:
    2010
  • 资助金额:
    $ 19.07万
  • 项目类别:
17th Congress of the International Organization for Mycoplasmology
国际支原体学组织第十七届大会
  • 批准号:
    7477409
  • 财政年份:
    2008
  • 资助金额:
    $ 19.07万
  • 项目类别:
16th Congress of the International Organization
国际组织第十六届大会
  • 批准号:
    7112186
  • 财政年份:
    2006
  • 资助金额:
    $ 19.07万
  • 项目类别:
15th Congress of Internat. Organ. for Mycoplasmology
第十五届国际代表大会
  • 批准号:
    6804881
  • 财政年份:
    2004
  • 资助金额:
    $ 19.07万
  • 项目类别:
Mycoplasma pneumoniae Gliding Motility
肺炎支原体滑行运动
  • 批准号:
    6723643
  • 财政年份:
    2002
  • 资助金额:
    $ 19.07万
  • 项目类别:
Mycoplasma pneumoniae Gliding Motility
肺炎支原体滑行运动
  • 批准号:
    6884626
  • 财政年份:
    2002
  • 资助金额:
    $ 19.07万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 19.07万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 19.07万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 19.07万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 19.07万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 19.07万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 19.07万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 19.07万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 19.07万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 19.07万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 19.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了